Common Stock, Shares, Outstanding of nCino, Inc. from 31 Jan 2021 to 31 Oct 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
nCino, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Jan 2021 to 31 Oct 2025.
  • nCino, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Oct 2025 was 114,434,810, a 1.1% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

nCino, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 114,434,810 -1,215,775 -1.1% 31 Oct 2025 10-Q 03 Dec 2025 2026 Q3
Q2 2025 115,444,919 +57,610 +0.05% 31 Jul 2025 10-Q 26 Aug 2025 2026 Q2
Q1 2025 115,240,618 +900,731 +0.79% 30 Apr 2025 10-Q 28 May 2025 2026 Q1
Q4 2024 115,996,852 +2,312,553 +2% 31 Jan 2025 10-Q 03 Dec 2025 2026 Q3
Q3 2024 115,650,585 +2,619,855 +2.3% 31 Oct 2024 10-Q 04 Dec 2024 2025 Q3
Q2 2024 115,387,309 +2,725,649 +2.4% 31 Jul 2024 10-Q 27 Aug 2024 2025 Q2
Q1 2024 114,339,887 +2,139,406 +1.9% 30 Apr 2024 10-Q 29 May 2024 2025 Q1
Q4 2023 113,684,299 +2,260,167 +2% 31 Jan 2024 10-K 01 Apr 2025 2025 FY
Q3 2023 113,030,730 +2,087,161 +1.9% 31 Oct 2023 10-Q 29 Nov 2023 2024 Q3
Q2 2023 112,661,660 +2,045,610 +1.8% 31 Jul 2023 10-Q 29 Aug 2023 2024 Q2
Q1 2023 112,200,481 +2,071,920 +1.9% 30 Apr 2023 10-Q 31 May 2023 2024 Q1
Q4 2022 111,424,132 +1,645,590 +1.5% 31 Jan 2023 10-K 26 Mar 2024 2024 FY
Q3 2022 110,943,569 31 Oct 2022 10-Q 30 Nov 2022 2023 Q3
Q2 2022 110,616,050 31 Jul 2022 10-Q 01 Sep 2022 2023 Q2
Q1 2022 110,128,561 30 Apr 2022 10-Q 01 Jun 2022 2023 Q1
Q4 2021 109,778,542 +16,134,783 +17% 31 Jan 2022 10-K 28 Mar 2023 2023 FY
Q4 2020 93,643,759 31 Jan 2021 10-K 31 Mar 2022 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.